Central retinal artery occlusion: Difference between revisions

(Created page with "==Etiology== Retinal Embolism (20%) Atherosclerotic changes Angiospasm Inflammatory Endarteritis ==Epidemiology== Bilateral 1-2% M>F ==Symptoms== Painless, mono...")
 
(Strip excess bold)
 
(58 intermediate revisions by 10 users not shown)
Line 1: Line 1:
==Background==
*Acute interruption of blood flow to the retinal artery causing retinal ischemia
*A stroke equivalent — 15-25% of patients will have an acute stroke or TIA within 1 week<ref name="lee">Lee J, et al. Risk of stroke in patients hospitalized with central retinal artery occlusion. ''Stroke''. 2013;44(4):967-971. PMID 23399955.</ref>
*'''Ophthalmologic emergency''' — retinal tolerance for ischemia is approximately 90-100 minutes
*Permanent vision loss occurs in most patients despite treatment
*Average age: 60-65 years
*Most common cause: thromboembolism from carotid artery atherosclerosis or cardiac source
==Etiology==
==Etiology==
*Carotid artery atherosclerosis (most common)
*Cardiac embolism (atrial fibrillation, valvular disease, endocarditis)
*Giant cell arteritis (GCA) — '''must be excluded in patients >50'''
*Hypercoagulable states
*Vasculitis
*Dissection of carotid or ophthalmic artery


==Clinical Features==
*Sudden, painless, monocular vision loss — often described as "lights went out"
*Typically develops over seconds
*Severe visual acuity loss (often counting fingers or light perception only)
*Relative afferent pupillary defect (APD / Marcus Gunn pupil)
*Fundoscopy:
**Pale/white retina with cherry-red spot at fovea (pathognomonic)
**Box-car segmentation of retinal vessels (intermittent blood flow)
**Retinal edema
*Branch RAO: visual field defect corresponding to affected branch


Retinal Embolism (20%)
==Differential Diagnosis==
 
*[[Central retinal vein occlusion]] (hemorrhages on fundoscopy, less acute)
Atherosclerotic changes
*[[Retinal detachment]]
 
*[[Optic neuritis]] (painful with eye movement)
Angiospasm
*[[Vitreous hemorrhage]]
 
*[[Giant cell arteritis]] (GCA) with anterior ischemic optic neuropathy
Inflammatory Endarteritis
*[[Stroke (main)|Stroke]] affecting visual cortex
 
 
==Epidemiology==
 
 
Bilateral 1-2%
 
M>F
 
 
==Symptoms==
 
 
Painless, monocular loss of vision
 
 
==DDx==
 
 
Amaurosis fugax (painless, fleeting; nl exam)
 
CRVO (painless, over hours; blood and thunder)
 
Temporal Arteritis
 
Acute glaucoma (blurry vision, eye pain)
 
 
==Exam==
 
 
Pale retina with edema
 
Cherry red spot at the macula
 
APD
 
Boxcar segmentation of blood column
 
 
==W/U==
 
 
Fundoscopic exam
 
CBC, ESR, EKG
 
 
==Treatment==
 
 
1. Ocular massage
 
2. Anterior chamber paracentesis
 
3. Intraarterial fibrinolysis
 
4. Acetazolamide
 
5. Mannitol
 
6. Timolol
 
7. Steroids
 
8. Hyperbarics (most effective if within 2-12h of presentation)
 
 
==Dispo==
 
 
Admit: comorbid disease
 
D/C: f/u with ophtho in 1-4 weeks
 
 
==Source==


==Evaluation==
*'''ESR and CRP''' — '''stat''' to evaluate for giant cell arteritis (ESR >50 in GCA)
**If GCA suspected: start treatment immediately (see below)
*Fundoscopic exam — cherry-red spot diagnostic
*Intraocular pressure (IOP) — rule out [[Acute angle-closure glaucoma|acute glaucoma]]
*CT/CTA head and neck — evaluate for stroke, carotid stenosis
**May also obtain CTA to look for embolic source
*ECG — evaluate for atrial fibrillation
*Echocardiogram — evaluate for cardiac embolic source
*Labs: CBC, BMP, coagulation studies, lipid panel, HbA1c
*MRI with DWI — assess for concurrent acute stroke


H-N
==Management==
*'''No proven treatment''' reliably restores vision; most interventions have limited evidence<ref name="mac">Mac Grory B, et al. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. ''Stroke''. 2021;52(6):e282-e294. PMID 33843236.</ref>
*Traditional temporizing measures (limited evidence):
**Ocular massage — intermittent digital pressure over closed eyelid (10-15 seconds on, 5 seconds off)
**Attempt to dislodge embolus distally
*Emergent ophthalmology consultation
*If GCA suspected (age >50, elevated ESR, headache, jaw claudication):
**Methylprednisolone 1 g IV daily x 3 days or Prednisone 1 mg/kg PO
**Do NOT wait for temporal artery biopsy to start treatment
*Stroke workup: same as [[TIA]] / [[Stroke (main)|stroke]]
**Dual antiplatelet therapy, statin, carotid imaging
*Consider emergent catheter-directed intra-arterial thrombolysis (tPA) at specialized centers if <6 hours (experimental)


==Disposition==
*Admit for stroke workup (telemetry, vascular imaging, echocardiography)
*Emergent ophthalmology consultation
*If GCA suspected: admit for IV steroids and temporal artery biopsy within 1-2 weeks
*Treat as stroke equivalent with aggressive risk factor modification


==See Also==
*[[Central retinal vein occlusion]]
*[[Retinal detachment]]
*[[Stroke (main)]]
*[[Giant cell arteritis]]
*[[Acute angle-closure glaucoma]]


==References==
<references/>


[[Category:Ophtho]]
[[Category:Ophthalmology]]
[[Category:Neurology]]

Latest revision as of 09:26, 22 March 2026

Background

  • Acute interruption of blood flow to the retinal artery causing retinal ischemia
  • A stroke equivalent — 15-25% of patients will have an acute stroke or TIA within 1 week[1]
  • Ophthalmologic emergency — retinal tolerance for ischemia is approximately 90-100 minutes
  • Permanent vision loss occurs in most patients despite treatment
  • Average age: 60-65 years
  • Most common cause: thromboembolism from carotid artery atherosclerosis or cardiac source

Etiology

  • Carotid artery atherosclerosis (most common)
  • Cardiac embolism (atrial fibrillation, valvular disease, endocarditis)
  • Giant cell arteritis (GCA) — must be excluded in patients >50
  • Hypercoagulable states
  • Vasculitis
  • Dissection of carotid or ophthalmic artery

Clinical Features

  • Sudden, painless, monocular vision loss — often described as "lights went out"
  • Typically develops over seconds
  • Severe visual acuity loss (often counting fingers or light perception only)
  • Relative afferent pupillary defect (APD / Marcus Gunn pupil)
  • Fundoscopy:
    • Pale/white retina with cherry-red spot at fovea (pathognomonic)
    • Box-car segmentation of retinal vessels (intermittent blood flow)
    • Retinal edema
  • Branch RAO: visual field defect corresponding to affected branch

Differential Diagnosis

Evaluation

  • ESR and CRPstat to evaluate for giant cell arteritis (ESR >50 in GCA)
    • If GCA suspected: start treatment immediately (see below)
  • Fundoscopic exam — cherry-red spot diagnostic
  • Intraocular pressure (IOP) — rule out acute glaucoma
  • CT/CTA head and neck — evaluate for stroke, carotid stenosis
    • May also obtain CTA to look for embolic source
  • ECG — evaluate for atrial fibrillation
  • Echocardiogram — evaluate for cardiac embolic source
  • Labs: CBC, BMP, coagulation studies, lipid panel, HbA1c
  • MRI with DWI — assess for concurrent acute stroke

Management

  • No proven treatment reliably restores vision; most interventions have limited evidence[2]
  • Traditional temporizing measures (limited evidence):
    • Ocular massage — intermittent digital pressure over closed eyelid (10-15 seconds on, 5 seconds off)
    • Attempt to dislodge embolus distally
  • Emergent ophthalmology consultation
  • If GCA suspected (age >50, elevated ESR, headache, jaw claudication):
    • Methylprednisolone 1 g IV daily x 3 days or Prednisone 1 mg/kg PO
    • Do NOT wait for temporal artery biopsy to start treatment
  • Stroke workup: same as TIA / stroke
    • Dual antiplatelet therapy, statin, carotid imaging
  • Consider emergent catheter-directed intra-arterial thrombolysis (tPA) at specialized centers if <6 hours (experimental)

Disposition

  • Admit for stroke workup (telemetry, vascular imaging, echocardiography)
  • Emergent ophthalmology consultation
  • If GCA suspected: admit for IV steroids and temporal artery biopsy within 1-2 weeks
  • Treat as stroke equivalent with aggressive risk factor modification

See Also

References

  1. Lee J, et al. Risk of stroke in patients hospitalized with central retinal artery occlusion. Stroke. 2013;44(4):967-971. PMID 23399955.
  2. Mac Grory B, et al. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. Stroke. 2021;52(6):e282-e294. PMID 33843236.